1649P Impact of concomitant medications on safety in patients with high-volume metastatic hormone-sensitive prostate cancer (mHSPC) receiving rezvilutamide (Rez) plus androgen-deprivation therapy (ADT): A post-hoc analysis of the randomized phase III CHART trial
Year: 2024
Type: article
Source: Annals of Oncology
Institutions: Fudan University, Fudan University Shanghai Cancer Center, Lanzhou University Second Hospital, Jiangsu Province Hospital, Lanzhou University, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Affiliated Hospital of Hebei University, Jilin University, Northern Jiangsu People's Hospital, Huadong Hospital, Zhongshan Hospital, First Affiliated Hospital of Fujian Medical University, Peking University Cancer Hospital, Liaoning Cancer Hospital & Institute, First Hospital of Jilin University, First Bethune Hospital of Jilin University, Henan Provincial People's Hospital, Fourth Hospital of Hebei Medical University, Hunan Cancer Hospital, Jiangsu Hengrui Medicine (China)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4402704947